OptimizeRx Corp. (NASDAQ: OPRX), a healthcare technology company providing digital solutions for life sciences companies, announced that it has secured a $35 million senior secured credit facility with Fifth Third Bank. The facility includes a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as the financial advisor for the transaction.
The new credit facility strengthens OptimizeRx's balance sheet and provides additional liquidity to support the company's growth strategy, including potential acquisitions, product development, and working capital needs. The company's platform leverages artificial intelligence-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver targeted engagement between life science brands and healthcare providers and patients.
OptimizeRx focuses on privacy-safe, patient-centric technology to improve treatment decisions and patient outcomes. By bridging healthcare professional and direct-to-consumer strategies, the company enables synchronized marketing solutions. The credit facility underscores the confidence of Fifth Third Bank in OptimizeRx's business model and growth prospects.
For more details on the announcement, visit here. Additional information about OptimizeRx is available at www.optimizerx.com.
